Financial factors aren't the only things that are worth paying attention to.Investing in biopharma stocks isn't for everyone. Between the need to comprehend subtle medical or scientific factors to the often Byzantine world of clinical and regulatory catalysts, there is an abundance of opportunities for informed investors to reap big rewards -- and for misinformed or underinformed investors to lose their shirts.The good news is that if you're willing to put in a bit of effort, it's very possible to improve o ...